Medi Caps has accepted the resignations of Ramesh Chandra Mittal and Kusum Mittal from its Board of Directors, effective close of business hours on August 6, 2026. The departures, driven by personal health concerns, remove the company’s Chairperson and a key non-executive director from their roles simultaneously. This leadership change marks a significant transition for the pharmaceutical firm, requiring the Board to address succession planning for the Chairperson role in its immediate future.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Sub-Para 7(C) of Para A of Part A of Schedule III. The filing confirms that both directors have tendered their resignation letters dated July 30, 2026. The company stated that there are no material reasons for the resignations other than those explicitly stated in the respective letters. The resignation letters will be placed before the Board of Directors in the upcoming Board Meeting for formal consideration and acceptance in accordance with applicable laws.

Ramesh Chandra Mittal, who held the position of Chairperson as well as Non-Executive Non-Independent Director, cited his inability to devote the required time and attention to discharge his responsibilities due to personal health concerns. Similarly, Kusum Mittal, serving as a Non-Executive Non-Independent Director, resigned for the same reason. Both directors confirmed in writing that no other material factors influenced their decision to step down.

The Board of Directors expressed appreciation for the invaluable guidance, leadership, and dedicated services rendered by both individuals during their association with the company. The resignations take effect at the close of business hours on August 6, 2026, meaning both directors will cease to hold office immediately following that date.

Resignation Details

The company is required to file requisite e-forms and make necessary submissions with the Registrar of Companies and BSE Limited. The disclosure was signed by Alok K. Garg, Managing Director of Medi Caps Limited.

Medi-Caps Limited announced that Mr. Hemant Sethi has resigned from the position of Chief Financial Officer and Key Managerial Personnel (KMP) effective the close of business hours on June 6, 2026. The resignation was tendered via a letter dated June 3, 2026, and was submitted to pursue career growth and professional opportunities. Mr. Sethi confirmed that there are no other material reasons for his departure beyond those stated.

Consequently, Mr. Sethi ceased to be the KMP authorized to determine the materiality of events or information and to make disclosures to stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board of Directors will place the resignation letter before an upcoming Board meeting for consideration and formal acceptance in accordance with regulations.

The company expressed its appreciation for the valuable services rendered by Mr. Sethi during his tenure. The disclosure was made in compliance with Regulation 30 read with Schedule III of the SEBI Listing Regulations and subsequent circulars issued by the Securities and Exchange Board of India (SEBI).

Resignation Details

The following table outlines the key particulars regarding the change in the company's leadership:

The information was submitted to BSE Limited by Abhishek Jain, Company Secretary and Compliance Officer for Medi-Caps Limited.